Cargando…
The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo
Human T-cell leukemia virus type 1 (HTLV-1) is the infectious cause of adult T-cell leukemia/lymphoma (ATL), an extremely aggressive and fatal malignancy of CD4(+) T-cells. Due to the chemotherapy-resistance of ATL and the absence of long-term therapy regimens currently available for ATL patients, t...
Autores principales: | Ernzen, Kyle, Melvin, Corrine, Yu, Lianbo, Phelps, Cameron, Niewiesk, Stefan, Green, Patrick L., Panfil, Amanda R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932813/ https://www.ncbi.nlm.nih.gov/pubmed/36819050 http://dx.doi.org/10.3389/fmicb.2023.1101544 |
Ejemplares similares
-
Regulation of HTLV-1 transformation
por: Ernzen, Kyle J., et al.
Publicado: (2022) -
HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development
por: Maksimova, Victoria, et al.
Publicado: (2023) -
HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
por: Maksimova, Victoria, et al.
Publicado: (2022) -
PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival
por: Panfil, Amanda R., et al.
Publicado: (2015) -
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor
with Robust in Vivo Activity
por: Campbell, John E., et al.
Publicado: (2015)